Replies to post #6138 on ANI Pharmaceuticals (ANIP)

[Jp2011]

Jtfm,

If Hypertension is truly the opportunity we all think it is, I am amazed ANI is not exponentially more aggressive.

I understand the hurdles with the patents but I still think they are missing their golden opportunity with too much patience. I know you got the message out in your SA Article but I wish something else could be done.